HKU Scholars Hub: Search

Search

Results 1-25 of 753 (Search time: 0.01 seconds).

previous
1
2
3
4
...
31
next

	Title	Author(s)	Issue Date
	The activity of liver-enriched and growth-suppressive transcription factor CREB-H is tightly regulated by N-linked glycosylation and ubiquitination Proceeding/Conference:CSHL Meeting on Mechanisms & Models of Cancer	Chan, CP Mak, TY Chin, KT Ng, IOL Jin, D	2010
	Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection Journal:PLoS ONE	Chan, KYK Wong, CM Kwan, JSH Lee, JMF Cheung, KW Yuen, MF Lai, CL Poon, RTP Sham, PC Ng, IOL	2011
	Histological outcome after liver transplantation for chronic hepatitis B using oral antiviral therapy alone without hepatitis B immune globulin Proceeding/Conference:Liver Transplantation	Fung, J Lo, R Chan, SC Chok, KSH Sharr, WW Dai, WC Cheung, TT Chan, ACY Wong, T Ng, IOL Yuen, MF Lo, CM	2014
	Histone Chaperone FACT complex mediates oxidative stress response to promote liver cancer progression Journal:Gut	SHEN, J CHEN, M LEE, D LAW, C-T Wei, L Tsang, FH-C Chin, DW-C Cheng, CL-H Lee, JM-F Ng, IO-L Wong, CC-L Wong, C-M	2020
	Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization Journal:International Journal of Biological Sciences	Fako, V Martin, SP Pomyen, Y Budhu, A Chaisaingmongkol, J Franck, S Lee, JM-F Ng, IO-L Cheung, T-T Wei, X Liu, N Ji, J Zhao, Lei Liu, Z Jia, H-L Tang, Z-Y Qin, L-X Kloeckner, R Marquardt, J Greten, T Wang, XW	2019
	Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC Journal:Nature Communications	Wei, L LEE, D Law, C-T Zhang, MS SHEN, J Chin, DW-C Zhang, A Tsang, FH-C WONG, CL-S Ng, IO-L Wong, CC-L Wong, C-M	2019
	Joining the dots for better liver cancer treatment Journal:Nature Reviews Gastroenterology & Hepatology	Chan, L-K Ng, IO-L	2020
	Antioxidant supplements may enhance tumor initiation and growth in hepatocellular carcinoma and counteract the therapeutic effects of Sorafenib Proceeding/Conference:American Association for Cancer Research (AACR) Annual Meeting	Zhang, X Lee, E Tsui, YM Sze, MF Chiu, YT Chan, LK Ho, DWH Lee, MF Wong, CCL Ng, IOL	2020
	Molecular pathogenesis of hepatocellular carcinoma Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2010	Ng, IOL	2010
	Proteomic profiling in liver cancer: another new page Journal:Translational Gastroenterology and Hepatology	Chan, LK Ng, IOL	2019
	Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing Poliovirus Receptor and Inhibiting the Cytotoxic T-cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice Journal:Gastroenterology	Chiu, DKC Yuen, VWH Cheu, JWS Wei, LL Ting, V Fehlings, M Sumatoh, H Nardin, A Newell, EW Ng, IOL Yau, TCC Wong, CM Wong, CCL	2020
	The tumor suppressive function of AMPK in hepatocellular carcinoma Proceeding/Conference:Cancer Research	Liu, MHF Leong, VYL Ng, IOL Ching, YP	2007
	Regulation of the tumour metastasis suppressor gene, NM23, by p21-activated protein kinase 5 Proceeding/Conference:Annual Meeting of the American Association for Cancer Research, AACR 2004	Ching, YP Leong, VYL Jin, D Ng, IOL	2004
	Characterization of a novel MAD1 isoform, MAD1β, in hepatocellular carcinoma Proceeding/Conference:Research Postgraduate Symposium, RPS 2006	Sze, MF Ching, YP Jin, D Ng, IOL	2006
	Identification of a novel RHO GTPase activating protein called DLC2, involved in hepatocellular carcinoma Proceeding/Conference:International Symposium of the Society of Chinese Bioscientistis in America, SCBA 2004	Ching, YP Wong, CM Jin, D Ng, IOL	2004
	Upregulation of NF-kB signaling pathway in hepatocellular carcinoma Proceeding/Conference:World Congress of Digestive Surgery & HKICC 2002	Chan, CF Yau, TO Jin, D Ng, IOL	2002
	Genetic and epigenetic alterations on DLC-1 gene in hepatocellular carcinoma Proceeding/Conference:Proceedings of the American Association for Cancer Research	Wong, CM Ching, YP Lee, MF Jin, D Ng, IOL	2003
	Deleted in Liver Cancer 2, DLC2, suppresses cell transformation via inhibition of rhoa activity Proceeding/Conference:Research Postgraduate Symposium, RPS 2005	Leung, THY Ching, YP Yam, JWP Yau, TO Jin, D Ng, IOL	2005
	Characterisation of steroidogenic acute regulatory protein related lipid transfer domain (START)domain in deleted in Liver Cancer 2(DLC-2) Proceeding/Conference:International Symposium of the Society of Chinese Bioscientists in America, SCBA 2004	Ng, DCH Jin, D Ng, IOL	2004
	Characterization of novel putative tumor suppressor gene, DLC2 (deleted in liver cancer 2), in hepatocellular carcinoma Proceeding/Conference:Cancer Research	Leung, HY Ching, YP Wong, CM Ng, DCH Jin, D Ng, IOL	2004
	Dysregulation of mitotic spindle checkpoint control in hepatocellular carcinomas Proceeding/Conference:Cancer Research	Sze, MF Ching, YP Jin, D Ng, IOL	2004
	Identification of multiple isoforms of DLC2, a novel tumor suppressor gene, and their functional characterization in hepatocellular carcinoma Proceeding/Conference:International Meeting of Hepatocellular Carcinoma, HCC 2004	Leung, THY Ching, YP Wong, CM Ng, DCH Jin, D Ng, IOL	2004
	Interaction of deleted in liver cancer 1 (DLC1) with tensin2 and its implications in tumor suppression Proceeding/Conference:Cancer Research	Ko, FCF Yam, JWP Chan, PCY Jin, D Ng, IOL	2006
	Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma Proceeding/Conference:Inaugural Queenstown Signal Transduction Meeting	Yam, JWP Ko, FCF Chan, PCY Yau, TO Tung, KK Leung, THY Jin, D Ng, IOL	2006
	Dysregulation of mitotic spindle checkpoint control in hepatocellular carcinomas Proceeding/Conference:Research Postgraduate Symposium, RPS 2005	Sze, MF Ching, YP Jin, D Ng, IOL	2005